Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS).
Shinichiro YamadaAtsushi HashizumeYasuhiro HijikataTomonori InagakiDaisuke ItoFumie KinoshitaMasahiro NakatochiYumiko KobayashiAkihiro HirakawaTomohiko NakamuraMasahisa KatsunoPublished in: BMJ open (2018)
UMIN000026150; Pre-results.